Search research articles
Contact Us
Filters
Showing results (71-80 of 180) with videos related to
Page
of 18
Sort By:
Anticancer Research
|
March 16, 2016
Adaptive Immune Response to and Survival Effect of Temozolomide- and Valproic Acid-induced Autophagy in Glioblastoma
Judith Proske, Lisa Walter, Elisabeth Bumes, et al.
Cancer Medicine
|
December 11, 2019
Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma
Tareq M Anssar, Michael F Leitzmann, Ralf A Linker, et al.
International Journal of Cancer
|
September 24, 2004
Inhibition of immunosuppressive effects of melanoma-inhibiting activity (MIA) by antisense techniques
Piotr Jachimczak, Rainer Apfel, Anja-Kathrin Bosserhoff, et al.
Clinical Neuropathology
|
November 14, 2013
Polyarteritis nodosa complicating multiple myeloma - a case report and review of the literature
Markus Hutterer, Michael Steurer, Romana Höftberger, et al.
CNS Oncology
|
June 20, 2018
Efficacy of D,L-methadone in the treatment of glioblastoma in vitro
Konstantin Brawanski, Gero Brockhoff, Peter Hau, et al.
Cancer Medicine
|
December 2, 2024
Targeted agents in patients with progressive glioblastoma-A systematic meta-analysis of randomized clinical trials
Franziska Maria Ippen, Angelika Scherm, Tobias Kessler, et al.
Neurology Research International
|
July 23, 2015
Inventory of a Neurological Intensive Care Unit: Who Is Treated and How Long?
Roland Backhaus, Franz Aigner, Felix Schlachetzki, et al.
Journal of Neuro-Oncology
|
June 4, 2004
Maintenance therapy with 13-cis retinoid acid in high-grade glioma at complete response after first-line multimodal therapy--a phase-II study
Caecilia Wismeth, Peter Hau, Klaus Fabel, et al.
Journal of Neuro-Oncology
|
December 25, 2009
Transcranial electro-hyperthermia combined with alkylating chemotherapy in patients with relapsed high-grade gliomas: phase I clinical results
Caecilia Wismeth, Christine Dudel, Christina Pascher, et al.
Oncotarget
|
October 10, 2015
TGF-ß isoforms in cancer: Immunohistochemical expression and Smad-pathway-activity-analysis in thirteen major tumor types with a critical appraisal of antibody specificity and immunohistochemistry assay validity
Markus J Riemenschneider, Maria Hirblinger, Arabel Vollmann-Zwerenz, et al.
Page
of 18
Search research articles
Search
Showing results (71-80 of 180) with videos related to
Sort By:
Page
of 18
Anticancer Research
|
March 16, 2016
Adaptive Immune Response to and Survival Effect of Temozolomide- and Valproic Acid-induced Autophagy in Glioblastoma
Judith Proske, Lisa Walter, Elisabeth Bumes, et al.
Cancer Medicine
|
December 11, 2019
Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma
Tareq M Anssar, Michael F Leitzmann, Ralf A Linker, et al.
International Journal of Cancer
|
September 24, 2004
Inhibition of immunosuppressive effects of melanoma-inhibiting activity (MIA) by antisense techniques
Piotr Jachimczak, Rainer Apfel, Anja-Kathrin Bosserhoff, et al.
Clinical Neuropathology
|
November 14, 2013
Polyarteritis nodosa complicating multiple myeloma - a case report and review of the literature
Markus Hutterer, Michael Steurer, Romana Höftberger, et al.
CNS Oncology
|
June 20, 2018
Efficacy of D,L-methadone in the treatment of glioblastoma in vitro
Konstantin Brawanski, Gero Brockhoff, Peter Hau, et al.
Cancer Medicine
|
December 2, 2024
Targeted agents in patients with progressive glioblastoma-A systematic meta-analysis of randomized clinical trials
Franziska Maria Ippen, Angelika Scherm, Tobias Kessler, et al.
Neurology Research International
|
July 23, 2015
Inventory of a Neurological Intensive Care Unit: Who Is Treated and How Long?
Roland Backhaus, Franz Aigner, Felix Schlachetzki, et al.
Journal of Neuro-Oncology
|
June 4, 2004
Maintenance therapy with 13-cis retinoid acid in high-grade glioma at complete response after first-line multimodal therapy--a phase-II study
Caecilia Wismeth, Peter Hau, Klaus Fabel, et al.
Journal of Neuro-Oncology
|
December 25, 2009
Transcranial electro-hyperthermia combined with alkylating chemotherapy in patients with relapsed high-grade gliomas: phase I clinical results
Caecilia Wismeth, Christine Dudel, Christina Pascher, et al.
Oncotarget
|
October 10, 2015
TGF-ß isoforms in cancer: Immunohistochemical expression and Smad-pathway-activity-analysis in thirteen major tumor types with a critical appraisal of antibody specificity and immunohistochemistry assay validity
Markus J Riemenschneider, Maria Hirblinger, Arabel Vollmann-Zwerenz, et al.
Page
of 18